Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Net revenue $ 94,000 [1] $ 108,000 [1] $ 157,000 [1] $ 700,000 [1]
Cost of sales 48,000 128,000 88,000 631,000
Gross profit (loss) 46,000 (20,000) 69,000 69,000
Operating expenses:        
Selling and administrative expenses 476,000 574,000 1,089,000 1,975,000
Amortization of prepaid advisory fees 427,000 445,000 1,252,000 1,275,000
Research and development 139,000 280,000 369,000 806,000
Total operating expenses 1,042,000 1,299,000 2,710,000 4,056,000
Operating loss (996,000) (1,319,000) (2,641,000) (3,987,000)
Other income (expense):        
Change in fair value of derivative liabilities (650,000) 254,000 (567,000) 3,826,000
Interest expense, net (41,000) (33,000) (141,000) (70,000)
Other expense (58,000) 0 (58,000) 0
Net loss $ (1,745,000) $ (1,098,000) $ (3,407,000) $ (231,000)
Net loss per share - basic and diluted $ (0.03) $ (0.02) $ (0.06) $ (0.01)
Weighted average number of common shares outstanding - basic and diluted 62,455,354 47,003,583 52,482,656 46,345,053
[1] Includes sales to related parties of approximately $0 and $31,000 for the three months ended March 31, 2014 and 2013, respectively, and approximately $3,000 and $62,000 for the nine months ended March 31, 2014 and 2013, respectively.